Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Add a short note if something mattered, such as cold pen stung more or breathing helped. Avoid turning the log into a list of worst-case predictions
Ayesha K.May 5, 2026 Ive been using this for about 3 weeks and my skin looks healthier and more even
Shen, M
Key findings from animal studies Superior body weight reduction compared to GLP-1 monoagonists in diet-induced obese rodent models Significant reduction in hepatic fat content in NASH models, suggesting relevance for metabolic liver disease research Improvements in lipid profiles (triglycerides, LDL cholesterol) beyond what was observed with GLP-1 monoagonism alone Evidence of increased energy expenditure supporting the glucagon receptor-mediated thermogenesis hypothesis Clinical Research Timeline (Updated Through 2026) Retatrutide has now progressed through Phase 3 clinical trials with three major readouts between December 2025 and May 2026, representing the most advanced clinical development of any triple hormone receptor agonist to date
Together, well navigate the complexities of these medications, ensuring that they can work for you without the hindrance of unpleasant side effects
